常染色体显性遗传性肾小管间质性肾病:遗传性慢性肾脏病的一个新兴病因
本文综述常染色体显性遗传性肾小管间质性肾病(ADTKD)的疾病分类演变,强调基于致病基因的分类体系包括ADTKD-UMOD、ADTKD-MUC1、ADTKD-REN、ADTKD-HNF1B及罕见的ADTKD-SEC61A1和ADTKD-DNAJB11;二代测序(NGS)提高了家族性肾病诊断准确性,ADTKD现被认为是全球第三大遗传性肾脏病病因;除HNF1B外,不同突变基因产生错误折叠蛋白导致细胞应激和细胞毒性。
要点
- ADTKD以进行性肾功能丧失、尿检无显著异常和肾小管间质纤维化为特征,成年期进展至终末期肾病(ESRD)。
- ADTKD分类基于受累基因,包括ADTKD-UMOD、ADTKD-MUC1、ADTKD-REN、ADTKD-HNF1B及罕见的ADTKD-SEC61A1和ADTKD-DNAJB11。
- NGS作为家族性肾脏病的诊断工具提高了诊断准确性,ADTKD被认为是全球第三大遗传性肾脏病病因,仅次于ADPKD和Alport综合征。
核心结论
- ADTKD是一种罕见的遗传性疾病,以进行性肾功能丧失、尿检无显著异常和肾小管间质纤维化为特征,成年期进展至ESRD。
- ADTKD分类应基于受累基因,涵盖ADTKD-UMOD、ADTKD-MUC1、ADTKD-REN、ADTKD-HNF1B及罕见的ADTKD-SEC61A1和ADTKD-DNAJB11。
- NGS提高了家族性肾脏病的诊断准确性,ADTKD现被认为是全球第三大遗传性肾脏病病因,仅次于ADPKD和Alport综合征。
- 除HNF1B外,不同突变基因产生错误折叠蛋白导致细胞应激和细胞毒性;研究聚焦于更好地定义纤维化 underlying 机制以指导治疗干预。
研究设计与样本
- 本文为综述,旨在讨论近几十年来ADTKD知识的演变,重点为不同ADTKD疾病的临床特征、分子诊断和致病机制。
主要发现
- ADTKD进展至ESRD发生在成年期。
- ADTKD分类是一个演变中的概念,目前共识为基于受累基因进行分类。
- ADTKD包括ADTKD-UMOD、ADTKD-MUC1、ADTKD-REN、ADTKD-HNF1B,以及近期描述的更罕见和不典型的ADTKD-SEC61A1和ADTKD-DNAJB11。
- NGS作为家族性肾脏病患者的诊断工具提高了该领域的诊断准确性。
- 除HNF1B外,不同突变基因产生错误折叠蛋白导致细胞应激和细胞毒性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Autosomal dominant tubulointerstitial kidney disease (ADTKD) is a rare inherited disorder characterized by progressive loss of kidney function, nonsignificant urinalysis and tubulointerstitial fibrosis. ADTKD progresses to end stage renal disease (ESRD) in adulthood. The classification of ADTKD is an evolving concept and the agreement is now that, due to the overlap in terms of phenotype characteristics, this should be based on the involved gene. The umbrella term ADTKD therefore includes different conditions as follows: ADTKD-UMOD, ADKTD-MUC1, ADTKD-REN, and ADTK-HNF1B, with ADTKD-SEC61A1 and ADTKD-DNAJB11 as a further rare and atypical diagnosis recently described. The employment of next-generation sequencing (NGS) as a diagnostic tool in patients with familial kidney disease has improved the diagnostic accuracy in this field with ADTKD now being considered the third genetic cause of renal disease worldwide after autosomal dominant polycystic kidney disease (ADPKD) and Alport syndrome. On average, the disease pathogenesis is similar across the different subtypes, With the exception of HNF1B, the different mutated genes give rise to misfolded proteins leading to cellular stress and cytotoxicity. Research is now focused in better defining the underlying mechanism of fibrosis to guide therapeutic interventions. The aim of this review is to discuss how the knowledge of ADTKD has evolved in the last decades, with emphasis on the clinical features, molecular diagnosis, and pathogenic aspects of the different diseases included under the ADTKD term.
引用
- Econimo L, Schaeffer C, Zeni L, et al. Autosomal Dominant Tubulointerstitial Kidney Disease: An Emerging Cause of Genetic CKD. Kidney Int Rep. 2022. PMID: 36531871. doi:10.1016/j.ekir.2022.08.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。